Article | June 9, 2020

Prospective Writing To Prepare Disclosure-Ready Clinical Trial Documentation

Source: TransPerfect

By Adiba Kausar, Clinical Trial Disclosure Administrator, TransPerfect Life Sciences

Medical Writing and Publishing

Throughout the course of a clinical trial, numerous types of documentation are collected and transformed into regulatory submissions, publications, and reports to answer specific research questions. The configuration of clinical documentation to meet regulatory requirements and target audiences often leads to time-consuming duplicate efforts. In addition, sometimes the clinical data utility of documentation is compromised while adapting it to regulatory requirements. Therefore, prospective writing approaches are being used to plan for data transparency requirements in later stages of clinical development.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: